Linking the YTH Domain to Cancer: the Importance of YTH Family Proteins in Epigenetics Rongkai Shi1, Shilong Ying1, Yadan Li1,Liyuanzhu 1,Xianwang2 and Hongchuan Jin1

Total Page:16

File Type:pdf, Size:1020Kb

Linking the YTH Domain to Cancer: the Importance of YTH Family Proteins in Epigenetics Rongkai Shi1, Shilong Ying1, Yadan Li1,Liyuanzhu 1,Xianwang2 and Hongchuan Jin1 Shi et al. Cell Death and Disease (2021) 12:346 https://doi.org/10.1038/s41419-021-03625-8 Cell Death & Disease REVIEW ARTICLE Open Access Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics Rongkai Shi1, Shilong Ying1, Yadan Li1,LiyuanZhu 1,XianWang2 and Hongchuan Jin1 Abstract N6-methyladenosine (m6A), the most prevalent and reversible modification of mRNA in mammalian cells, has recently been extensively studied in epigenetic regulation. YTH family proteins, whose YTH domain can recognize and bind m6A- containing RNA, are the main “readers” of m6A modification. YTH family proteins perform different functions to determine the metabolic fate of m6A-modified RNA. The crystal structure of the YTH domain has been completely resolved, highlighting the important roles of several conserved residues of the YTH domain in the specific recognition of m6A- modified RNAs. Upstream and downstream targets have been successively revealed in different cancer types and the role of YTH family proteins has been emphasized in m6A research. This review describes the regulation of RNAs by YTH family proteins, the structural features of the YTH domain, and the connections of YTH family proteins with human cancers. ● Facts Is evaluating structural differences in YTH domains the potential direction for exploring and explaining fi ● The effects of YTH proteins on RNA metabolism are the complex phenomena in this eld? ● Is a highly selective YTH domain inhibitor a 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; different but overlap to some degree. ● The structure of the YTH domain helps YTHDF potential therapeutic agent for cancer? ● proteins recognize and bind m6A-containing Is the existing structural information about the YTH transcripts. domain useful for guiding the rational design of ● Structural crystallography studies have elaborated selective YTH domain inhibitors? the molecular basis of YTH domains to read m6A- modified RNA. Introduction ● YTH proteins have different targets in different Since the 1950s, nucleotides, which are the basic cancers and are involved in almost every aspect of molecular components of RNA, have been found to tumorigenesis and cancer progression. undergo a number of chemical modifications on their adenosine (A), guanosine (G), cytidine (C), and uridine Open questions (U) nucleosides. Over 100 kinds of RNA modifications, such as hm5C, m1A, and m6A, have been found and ● What is the precise unified model of YTH proteins these modifications can affect the biogenesis, structure, in the regulation of m6A modification? Are these and function of RNA in different ways; these mod- proteins different or redundant? ifications have been the hotspots in epigenetics in recent years and still have great potential for explora- tion. N6-methyladenosine (m6A) has been considered Correspondence: Hongchuan Jin ([email protected]) 1Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang, Sir Run Run the most prevalent and reversible modification of Shaw Hospital, Cancer Center, Zhejiang University, Hangzhou, China mRNA in eukaryotic cells since its initial discovery in 2 Department of Medical Oncology, Sir Run Run Shaw Hospital, Medical School the 1970s1. m6A modification is generally located in the of Zhejiang University, Hangzhou, China These authors contributed equally: Rongkai Shi, Shilong Ying consensus motif DRACH (D = G, A, or U; R = GorA; Edited by F. Pentimalli © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Shi et al. Cell Death and Disease (2021) 12:346 Page 2 of 14 H = A, C, or U), which is enriched in the coding YTHDF1-3 sequence (CDS) and 3′ untranslated region (3′ UTR) of YTHDF1 selectively recognizes m6A-modified mRNAs – RNA1 4. The regulation of m6A depends on three via the YTH domain, promotes their loading into the important factors, “writers”, “erasers”,and“readers”. ribosome, and interacts with initiation factors to facilitate “Writers” and “erasers” add and remove m6A mod- their translation via the N-terminal domain18. In addition ifications to and from RNA, respectively, while “read- to mediating translation initiation, YTHDF1 can also bind ers” recognize m6A and affect the fate of RNA. to the m6A site in the CDS of some mRNAs to assist with Generally, m6A reader proteins can be divided into translation elongation19. Additionally, some research has three classes, which use the YTH domain (YTH family indicated that YTHDF1 may sometimes mediate the tar- – proteins), m6A switch mechanism (hnRNPC, hnRNPG, get transcript’s stability20 22. It is worth mentioning that and hnRNPA2B1), or common RNA-binding domain YTHDF1 is of great importance in the field of neu- and its flanking regions (IGF2BPs and hnRNPA2B1) to roscience since it was reported to be capable of inducing bind m6A-containing transcripts5. In recent years, axon regeneration23, regulating axon guidance24, and writers and erasers have been actively researched6,and thereby facilitating learning and memory25 by enhancing recently, the focus has gradually turned to readers, the translation of specific transcripts. Conversely, especially YTH family proteins, due to the application YTHDF2 selectively binds m6A-modified RNA and reg- of several novel methods. m6A-seq, based on antibody- ulates its degradation by recruiting the CCR4-NOT mediated capture and massively parallel sequencing, complex to accelerate RNA deadenylation10,26,27. helpsusidentifym6Asitesatthetranscriptomelevel. Another YTHDF2-mediated RNA degradation mechan- In addition to traditional methods such as RIP-seq, new ism is endoribonucleolytic cleavage via HRSP12-mediated techniques such as CLIP-seq and PAR-CLIP, based on bridging of YTHDF2-bound RNAs to RNase P/MRP, combining immunoprecipitation with in vivo UV through which a subset of circular RNAs is selectively crosslinking enhanced by photoactivatable ribonucleo- downregulated in an m6A-dependent manner28. The P/ – sides, help us identify the targets of m6A readers7 10. Q/N-rich N-terminal domain of YTHDF2 is responsible These methods are shedding new light on RNA mod- for its function in RNA decay, while its aa 101–200 region ifications. Therefore, we attempt to review the regula- interacts with the SH domain of CNOT1, and its aa 1–100 tion of transcripts by YTH family proteins, the region is the HRSP12 binding region. In addition, structural basis of the YTH domain, and the association YTHDF3 interacts with YTHDF1 to help promote protein of YTH family proteins with human cancers. translation, and with YTHDF2 to affect the decay of methylated mRNA transcripts29. There is also a model of YTH family proteins recognize m6A and regulate m6A regulation in which pre-mRNA is first recognized by RNA processes YTHDF3, which acts as an assigner, and YTHDF1 and m6A modification is regulated by RNA methyl- YTHDF2 then competitively interact with YTHDF3, thus transferase complexes—writers—and demethylases— determining the fate of the mRNA transcript30. Impor- erasers. To catalyze N6-methyladenosine (m6A) RNA tantly, recent studies have revealed that YTHDFs can be methylation, methyltransferase-like 3 (METTL3) and involved in liquid-liquid phase separation by binding human methyltransferase-like 14 (METTL14) form a multi-m6A-modified mRNA scaffolds and then forming stable heterodimer core complex with Wilms tumor 1- YTHDF–m6A–mRNA complexes. These complexes then associated protein (WTAP), which enables the complex partition into phase-separated compartments such as P to localize to nuclear speckles enriched with pre-mRNA bodies, stress granules, or neuronal RNA granules to processing factors11,12. Additionally, other adaptor decide whether the mRNA should be degraded, trans- proteins, such as RBM15/15B, VIRMA, and ZC3H13, lated, or undergo other events. Especially in stress granule have been shown to be important for facilitating the formation, YTHDF proteins are critical in recruiting – function of the methyltransferase complex13 15. mRNA to stress granules. In addition, this phase separa- Regarding demethylases, only fat mass and obesity- tion is significantly enhanced by mRNAs that contain associated (FTO) and AlkB homolog 5 (ALKBH5) have multiple m6A motifs. In contrast to mRNAs containing a been found to be available to catalyze m6A demethyla- single m6A site, mRNAs containing multiple m6A sites tion thus far16,17. The YTH domain, the structural basis tend to act as scaffolds for the binding of YTHDF proteins for the recognition and binding of m6A-modified RNA, to juxtapose their low-complexity domains and initiate – enables a series of proteins such as YTHDF1-3 and phase separation31 34. Remarkably, given that YTH YTHDC1-2 to act as readers in the
Recommended publications
  • SRC Antibody - N-Terminal Region (ARP32476 P050) Data Sheet
    SRC antibody - N-terminal region (ARP32476_P050) Data Sheet Product Number ARP32476_P050 Product Name SRC antibody - N-terminal region (ARP32476_P050) Size 50ug Gene Symbol SRC Alias Symbols ASV; SRC1; c-SRC; p60-Src Nucleotide Accession# NM_005417 Protein Size (# AA) 536 amino acids Molecular Weight 60kDa Product Format Lyophilized powder NCBI Gene Id 6714 Host Rabbit Clonality Polyclonal Official Gene Full Name V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) Gene Family SH2D This is a rabbit polyclonal antibody against SRC. It was validated on Western Blot by Aviva Systems Biology. At Aviva Systems Biology we manufacture rabbit polyclonal antibodies on a large scale (200-1000 Description products/month) of high throughput manner. Our antibodies are peptide based and protein family oriented. We usually provide antibodies covering each member of a whole protein family of your interest. We also use our best efforts to provide you antibodies recognize various epitopes of a target protein. For availability of antibody needed for your experiment, please inquire (). Peptide Sequence Synthetic peptide located within the following region: QTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGG This gene is highly similar to the v-src gene of Rous sarcoma virus. This proto-oncogene may play a role in the Description of Target regulation of embryonic development and cell growth. SRC protein is a tyrosine-protein kinase whose activity can be inhibited by phosphorylation by c-SRC kinase. Mutations in this gene could be involved in the
    [Show full text]
  • The Interplay Between Dysregulated Ion Transport and Mitochondrial Architecture As a Dangerous Liaison in Cancer
    International Journal of Molecular Sciences Review The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a Dangerous Liaison in Cancer Stine F. Pedersen 1,* , Mette Flinck 1 and Luis A. Pardo 2,* 1 Department of Biology, Faculty of Science, University of Copenhagen, 2100 Copenhagen, Denmark; mette.fl[email protected] 2 Oncophysiology Group, Max Planck Institute for Experimental Medicine, 37075 Göttingen, Germany * Correspondence: [email protected] (S.F.P.); [email protected] (L.A.P.) Abstract: Transport of ions and nutrients is a core mitochondrial function, without which there would be no mitochondrial metabolism and ATP production. Both ion homeostasis and mitochondrial phenotype undergo pervasive changes during cancer development, and both play key roles in driving the malignancy. However, the link between these events has been largely ignored. This review comprehensively summarizes and critically discusses the role of the reciprocal relationship between ion transport and mitochondria in crucial cellular functions, including metabolism, signaling, and cell fate decisions. We focus on Ca2+,H+, and K+, which play essential and highly interconnected roles in mitochondrial function and are profoundly dysregulated in cancer. We describe the transport and roles of these ions in normal mitochondria, summarize the changes occurring during cancer development, and discuss how they might impact tumorigenesis. Keywords: mitochondrial fission; mitochondrial fusion; calcium; pH; potassium; membrane potential; metabolism; apoptosis; cell cycle; metastasis Citation: Pedersen, S.F.; Flinck, M.; Pardo, L.A. The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a 1. Introduction Dangerous Liaison in Cancer. Int. J. Since the first observation of mitochondria in the 1840s, a century had to pass until it Mol.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Systematic Description of the Expression and Prognostic Value of M6A Regulators in Human Ovarian Cancer
    Systematic Description of the Expression and Prognostic Value of M6A Regulators in Human Ovarian Cancer Yuwei Chen Fujian Medical University Fujian Cancer Hospital Yang Sun ( [email protected] ) Fujian Cancer Hospital https://orcid.org/0000-0003-4224-8832 Xinbei Chen Fujian Medical University Fujian Cancer Hospital Siming Li Fujian Medical University Fujian Cancer Hospital Hongmei Xia Fujian Cancer Hospital Research Keywords: m6A regulators, m6A, ovarian cancer, Prognostic values, bioinformatics analysis. Posted Date: December 22nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-131682/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Systematic description of the expression and prognostic value of m6A regulators in human ovarian cancer 1 Yuwei Chen1, Yang Sun1*, Xinbei Chen1, Siming Li1, Hongmei Xia1 2 * Correspondence: 3 Yang Sun 4 [email protected] 5 Total words:5253 6 Total Figures and Tables: 11 Figures and 3 Tables 7 Keywords: m6A regulators, m6A, ovarian cancer, Prognostic values, 8 bioinformatics analysis. 9 Abstract 10 Background: N6-methyladenine (m6A) methylation, known as a kind of RNA 11 methylation regulator, has become a hotspot for research in the life sciences in recent 12 years. The existing studies revealed that m6A regulators helped to regulate the 13 progression of several malignant tumors. However, the expression mode and 14 prognostic value of m6A regulators in ovarian cancer have not been fully elucidated. 15 Methods: ONCOMINE, GEPIA, Human protein atlas, Kaplan-meier, UALCAN, 16 cBioPortal, GeneMANIA, DAVID, Sring, and Metascape were utilized in this study. 17 Results: In this study, through a comprehensive use of multiple database systems, 18 m6A regulators-induced mRNA and protein expression levels and their prognostic 19 value in the epithelial ovarian cancer of various histological types were analyzed.
    [Show full text]
  • A Novel Hypoxic Long Noncoding RNA KB-1980E6.3 Maintains Breast Cancer Stem Cell Stemness Via Interacting with IGF2BP1 to Facilitate C-Myc Mrna Stability
    Oncogene (2021) 40:1609–1627 https://doi.org/10.1038/s41388-020-01638-9 ARTICLE A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability 1 2 3 4 1 1 1 1 1 Pengpeng Zhu ● Fang He ● Yixuan Hou ● Gang Tu ● Qiao Li ● Ting Jin ● Huan Zeng ● Yilu Qin ● Xueying Wan ● 1 1 5 1 Yina Qiao ● Yuxiang Qiu ● Yong Teng ● Manran Liu Received: 15 June 2020 / Revised: 13 November 2020 / Accepted: 18 December 2020 / Published online: 19 January 2021 © The Author(s), under exclusive licence to Springer Nature Limited 2021. This article is published with open access Abstract The hostile hypoxic microenvironment takes primary responsibility for the rapid expansion of breast cancer tumors. However, the underlying mechanism is not fully understood. Here, using RNA sequencing (RNA-seq) analysis, we identified a hypoxia-induced long noncoding RNA (lncRNA) KB-1980E6.3, which is aberrantly upregulated in clinical breast cancer tissues and closely correlated with poor prognosis of breast cancer patients. The enhanced lncRNA KB- 1980E6.3 facilitates breast cancer stem cells (BCSCs) self-renewal and tumorigenesis under hypoxic microenvironment both 1234567890();,: 1234567890();,: in vitro and in vivo. Mechanistically, lncRNA KB-1980E6.3 recruited insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) to form a lncRNA KB-1980E6.3/IGF2BP1/c-Myc signaling axis that retained the stability of c-Myc mRNA through increasing binding of IGF2BP1 with m6A-modified c-Myc coding region instability determinant (CRD) mRNA. In conclusion, we confirm that lncRNA KB-1980E6.3 maintains the stemness of BCSCs through lncRNA KB-1980E6.3/ IGF2BP1/c-Myc axis and suggest that disrupting this axis might provide a new therapeutic target for refractory hypoxic tumors.
    [Show full text]
  • Pan-Cancer Analysis Identifies Mutations in SUGP1 That Recapitulate Mutant SF3B1 Splicing Dysregulation
    Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation Zhaoqi Liua,b,c,1, Jian Zhangd,1, Yiwei Suna,c, Tomin E. Perea-Chambleea,b,c, James L. Manleyd,2, and Raul Rabadana,b,c,2 aProgram for Mathematical Genomics, Columbia University, New York, NY 10032; bDepartment of Systems Biology, Columbia University, New York, NY 10032; cDepartment of Biomedical Informatics, Columbia University, New York, NY 10032; and dDepartment of Biological Sciences, Columbia University, New York, NY 10027 Contributed by James L. Manley, March 2, 2020 (sent for review January 2, 2020; reviewed by Kristen Lynch and Gene Yeo) The gene encoding the core spliceosomal protein SF3B1 is the most also resulted in the same splicing defects observed in SF3B1 frequently mutated gene encoding a splicing factor in a variety of mutant cells (11). hematologic malignancies and solid tumors. SF3B1 mutations in- In addition to SF3B1, other SF-encoding genes have also been duce use of cryptic 3′ splice sites (3′ss), and these splicing errors found to be mutated in hematologic malignancies, e.g., U2AF1, contribute to tumorigenesis. However, it is unclear how wide- SRSF2, and ZRSR2. However, these SF gene mutations do not spread this type of cryptic 3′ss usage is in cancers and what is share common alterations in splicing (1, 3), suggesting that dif- the full spectrum of genetic mutations that cause such missplicing. ferent splicing patterns may contribute to different phenotypes To address this issue, we performed an unbiased pan-cancer anal- of cancers. Because SF3B1 is the most frequently mutated ysis to identify genetic alterations that lead to the same aberrant splicing gene, the splicing defects caused by mutant SF3B1 may SF3B1 splicing as observed with mutations.
    [Show full text]
  • Crystal Structure of Histidine Triad Nucleotide- Binding Protein from the Pathogenic Fungus Candida Albicans
    Molecules and Cells Minireview Crystal Structure of Histidine Triad Nucleotide- Binding Protein from the Pathogenic Fungus Candida albicans Ahjin Jung1,6, Ji-Sook Yun1,6, Shinae Kim1, Sang Ryong Kim2, Minsang Shin3, Dong Hyung Cho2, Kwang Shik Choi2,4,5,*, and Jeong Ho Chang1,5,* 1Department of Biology Education, 2School of Life Sciences, BK21 Plus KNU Creative BioResearch Group, 3Department of Mi- crobiology, School of Medicine, 4Research Institute for Dokdo and Ulleungdo Island, Kyungpook National University, 5Research Institute for Phylogenomics and Evolution, Kyungpook National University, Daegu 41566, Korea, 6These authors contributed equally to this work. *Correspondence: [email protected] (KSC); [email protected] (JHC) http://dx.doi.org/10.14348/molcells.2018.0377 www.molcells.org Histidine triad nucleotide-binding protein (HINT) is a member of evolution. Further studies are required to address the func- of the histidine triad (HIT) superfamily, which has hydrolase tional significance of variations in the C-terminal region. This activity owing to a histidine triad motif. The HIT superfamily structural analysis of CaHINT provided important insights into can be divided to five classes with functions in galactose me- the molecular aspects of evolution within the HIT superfamily. tabolism, DNA repair, and tumor suppression. HINTs are high- ly conserved from archaea to humans and function as tumor Keywords: Candida albicans, crystal structure, histidine triad, suppressors, translation regulators, and neuropathy inhibitors. HIT family, HINT Although the structures of HINT proteins from various species have been reported, limited structural information is available for fungal species. Here, to elucidate the structural features INTRODUCTION and functional diversity of HINTs, we determined the crystal structure of HINT from the pathogenic fungus Candida albi- Histidine triad nucleotide-binding protein (HINT), which con- cans (CaHINT) in complex with zinc ions at a resolution of 2.5 tains three highly conserved histidines as catalytic residues, is Å.
    [Show full text]
  • An Integrated Approach to Comprehensively Map the Molecular Context of Proteins
    bioRxiv preprint doi: https://doi.org/10.1101/264788; this version posted February 13, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Liu et al. An integrated approach to comprehensively map the molecular context of proteins Xiaonan Liu1,2, Kari Salokas1,2, Fitsum Tamene1,2,3 and Markku Varjosalo1,2,3* 1Institute of Biotechnology, University of Helsinki, Helsinki 00014, Finland 2Helsinki Institute of Life Science, University of Helsinki, Helsinki 00014, Finland 3Proteomics Unit, University of Helsinki, Helsinki 00014, Finland *Corresponding author Abstract: Protein-protein interactions underlie almost all cellular functions. The comprehensive mapping of these complex cellular networks of stable and transient associations has been made available by affi nity purifi cation mass spectrometry (AP-MS) and more recently by proximity based labelling methods such as BioID. Due the advancements in both methods and MS instrumentation, an in-depth analysis of the whole human proteome is at grasps. In order to facilitate this, we designed and optimized an integrated approach utilizing MAC-tag combining both AP-MS and BioID in a single construct. We systematically applied this approach to 18 subcellular localization markers and generated a molecular context database, which can be used to defi ne molecular locations for any protein of interest. In addition, we show that by combining the AP-MS and BioID results we can also obtain interaction distances within a complex. Taken together, our combined strategy off ers comprehensive approach for mapping physical and functional protein interactions. Introduction: Majority of proteins do not function in isolation geting the endogenous bait protein, allowing and their interactions with other proteins defi ne purifi cation of the bait protein together with the their cellular functions.
    [Show full text]
  • The VE-Cadherin/Amotl2 Mechanosensory Pathway Suppresses Aortic InAmmation and the Formation of Abdominal Aortic Aneurysms
    The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang Karolinska Institute Evelyn Hutterer Karolinska Institute Sara Hultin Karolinska Institute Otto Bergman Karolinska Institute Maria Forteza Karolinska Institute Zorana Andonovic Karolinska Institute Daniel Ketelhuth Karolinska University Hospital, Stockholm, Sweden Joy Roy Karolinska Institute Per Eriksson Karolinska Institute Lars Holmgren ( [email protected] ) Karolinska Institute Article Keywords: arterial endothelial cells (ECs), vascular disease, abdominal aortic aneurysms Posted Date: June 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-600069/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms Yuanyuan Zhang1, Evelyn Hutterer1, Sara Hultin1, Otto Bergman2, Maria J. Forteza2, Zorana Andonovic1, Daniel F.J. Ketelhuth2,3, Joy Roy4, Per Eriksson2 and Lars Holmgren1*. 1Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, Sweden. 2Department of Medicine Solna, BioClinicum, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. 3Department of Cardiovascular and Renal Research, Institutet of Molecular Medicine, Univ. of Southern Denmark, Odense, Denmark 4Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm,
    [Show full text]
  • Protein Network Analyses of Pulmonary Endothelial Cells In
    www.nature.com/scientificreports OPEN Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension Sarath Babu Nukala1,8,9*, Olga Tura‑Ceide3,4,5,9, Giancarlo Aldini1, Valérie F. E. D. Smolders2,3, Isabel Blanco3,4, Victor I. Peinado3,4, Manuel Castell6, Joan Albert Barber3,4, Alessandra Altomare1, Giovanna Baron1, Marina Carini1, Marta Cascante2,7,9 & Alfonsina D’Amato1,9* Chronic thromboembolic pulmonary hypertension (CTEPH) is a vascular disease characterized by the presence of organized thromboembolic material in pulmonary arteries leading to increased vascular resistance, heart failure and death. Dysfunction of endothelial cells is involved in CTEPH. The present study describes for the frst time the molecular processes underlying endothelial dysfunction in the development of the CTEPH. The advanced analytical approach and the protein network analyses of patient derived CTEPH endothelial cells allowed the quantitation of 3258 proteins. The 673 diferentially regulated proteins were associated with functional and disease protein network modules. The protein network analyses resulted in the characterization of dysregulated pathways associated with endothelial dysfunction, such as mitochondrial dysfunction, oxidative phosphorylation, sirtuin signaling, infammatory response, oxidative stress and fatty acid metabolism related pathways. In addition, the quantifcation of advanced oxidation protein products, total protein carbonyl content, and intracellular reactive oxygen species resulted increased
    [Show full text]
  • Figure S1. Reverse Transcription‑Quantitative PCR Analysis of ETV5 Mrna Expression Levels in Parental and ETV5 Stable Transfectants
    Figure S1. Reverse transcription‑quantitative PCR analysis of ETV5 mRNA expression levels in parental and ETV5 stable transfectants. (A) Hec1a and Hec1a‑ETV5 EC cell lines; (B) Ishikawa and Ishikawa‑ETV5 EC cell lines. **P<0.005, unpaired Student's t‑test. EC, endometrial cancer; ETV5, ETS variant transcription factor 5. Figure S2. Survival analysis of sample clusters 1‑4. Kaplan Meier graphs for (A) recurrence‑free and (B) overall survival. Survival curves were constructed using the Kaplan‑Meier method, and differences between sample cluster curves were analyzed by log‑rank test. Figure S3. ROC analysis of hub genes. For each gene, ROC curve (left) and mRNA expression levels (right) in control (n=35) and tumor (n=545) samples from The Cancer Genome Atlas Uterine Corpus Endometrioid Cancer cohort are shown. mRNA levels are expressed as Log2(x+1), where ‘x’ is the RSEM normalized expression value. ROC, receiver operating characteristic. Table SI. Clinicopathological characteristics of the GSE17025 dataset. Characteristic n % Atrophic endometrium 12 (postmenopausal) (Control group) Tumor stage I 91 100 Histology Endometrioid adenocarcinoma 79 86.81 Papillary serous 12 13.19 Histological grade Grade 1 30 32.97 Grade 2 36 39.56 Grade 3 25 27.47 Myometrial invasiona Superficial (<50%) 67 74.44 Deep (>50%) 23 25.56 aMyometrial invasion information was available for 90 of 91 tumor samples. Table SII. Clinicopathological characteristics of The Cancer Genome Atlas Uterine Corpus Endometrioid Cancer dataset. Characteristic n % Solid tissue normal 16 Tumor samples Stagea I 226 68.278 II 19 5.740 III 70 21.148 IV 16 4.834 Histology Endometrioid 271 81.381 Mixed 10 3.003 Serous 52 15.616 Histological grade Grade 1 78 23.423 Grade 2 91 27.327 Grade 3 164 49.249 Molecular subtypeb POLE 17 7.328 MSI 65 28.017 CN Low 90 38.793 CN High 60 25.862 CN, copy number; MSI, microsatellite instability; POLE, DNA polymerase ε.
    [Show full text]
  • Migration of Thymic Pre-T Cells Regulates Development
    Alternative Splicing Controlled by Heterogeneous Nuclear Ribonucleoprotein L Regulates Development, Proliferation, and Migration of Thymic Pre-T Cells This information is current as of October 2, 2021. Marie-Claude Gaudreau, Florian Heyd, Rachel Bastien, Brian Wilhelm and Tarik Möröy J Immunol published online 20 April 2012 http://www.jimmunol.org/content/early/2012/04/20/jimmun ol.1103142 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/04/20/jimmunol.110314 Material 2.DC1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published April 20, 2012, doi:10.4049/jimmunol.1103142 The Journal of Immunology Alternative Splicing Controlled by Heterogeneous Nuclear Ribonucleoprotein L Regulates Development, Proliferation, and Migration of Thymic Pre-T Cells Marie-Claude Gaudreau,*,† Florian Heyd,‡ Rachel Bastien,* Brian Wilhelm,x and Tarik Mo¨ro¨y*,† The regulation of posttranscriptional modifications of pre-mRNA by alternative splicing is important for cellular function, devel- opment, and immunity.
    [Show full text]